Scarica il PDF del Fascicolo

Issue presentation

Vincenzo Nigro, Luisa Politano

25th Anniversary of the Founding of the World Muscle Society (1995-2020). The Contribution of Prof. Giovanni Nigro (1931-2017)

Luciano Merlini

Giovanni Nigro A note of remembrance

Lefkos T Middleton, MD, FRCP

Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies

Eric P. Hoffman

Giovanni Nigro and the Naples’s school: historical contribution to the knowledge of heart involvement in Duchenne/Becker muscular dystrophies

Luisa Politano

Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance

Lilia Oreto ^1,2, Gian Luca Vita ³, Giuseppe Mandraffino ^1,4, Scipione Carerj ², Maria Pia Calabrò ⁵, Roberta Manganaro ², Maurizio Cusmà-Piccione ², Maria Chiara Todaro ^2,6, Maria Sframeli ³, Maria Cinquegrani ⁴, Antonio Toscano ⁷, Giuseppe Vita ^3,7, Sonia Messina ^3,7, Concetta Zito ²

Quadriceps muscle strength in Duchenne muscular dystrophy and effect of corticosteroid treatment

Luciano Merlini ¹, Ilaria Cecconi ², Antonia Parmeggiani ², Duccio Maria Cordelli ², Ada Dormi ³

LGMD. Identification, description and classification

Corrado Angelini

Alpha-sarcoglycanopathy presenting as myalgia and hyperCKemia in two adults with a long-term follow-up. Case reports

Claudia Dosi ¹, Anna Rubegni1 ¹ Denise Cassandrini ¹, Alessandro Malandrini ², Lorenzo Maggi ³, M. Alice Donati ⁴, Filippo M. Santorelli ¹

Myotonic dystrophy type 2: the 2020 update

Giovanni Meola ^1,2

Late-onset myopathies: clinical features and diagnosis

Marianne de Visser

Panorama of the distal myopathies

Marco Savarese ^1,2, Jaakko Sarparanta ^1,2, Anna Vihola ^1,2,3, Per Harald Jonson ^1,2, Mridul Johari ^1,2, Salla Rusanen1 ^1,2, Peter Hackman ^1,2, Bjarne Udd ^1,2,4

Core myopathies – a short review

Haluk Topaloglu

Dominant or recessive mutations in the RYR1 gene causing central core myopathy in Brazilian patients

Leonardo Galleni Leão ¹, Lucas Santos Souza ¹, Letícia Nogueira ¹, Rita de Cássia Mingroni Pavanello ¹, Juliana Gurgel-Giannetti ², Umbertina C Reed ³, Acary S.B. Oliveira ⁴, Thais Cuperman ⁴, Ana Cotta ⁵, Julia FPaim ⁵, Mayana Zatz ¹, Mariz Vainzof ¹

The changing spectrum of drug-induced myopathies

Frank L. Mastaglia

Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications

Marinos C. Dalakas

Giant cell myositis and myocarditis revisited

Piraye Oflazer

The impact of SARS-CoV-2 on skeletal muscles

Maria Rita De Giorgio ^1,2, Stefania Di Noia ^2,3, Cinzia Morciano ^1,2, Diana Conte ^4,5

The correlation between cardiac and skeletal muscle pathology in animal models of idiopathic inflammatory myopathies

Francesco Prisco, Serenella Papparella, Orlando Paciello

Cutaneous and metabolic defects associated with nuclear abnormalities in a transgenic mouse model expressing R527H lamin A mutation causing mandibuloacral dysplasia type A (MADA) syndrome

Maria Rosaria D’Apice ¹, Angela De Dominicis ¹, Michela Murdocca ², Francesca Amati ², Annalisa Botta ², Federica Sangiuolo ^1,2, Giovanna Lattanzi ⁴, Massimo Federici ⁴, Giuseppe Novelli ^1,2,5,6

25 years of the SMN genes: the Copernican revolution of spinal muscular atrophy

Francesco Danilo Tiziano ¹, Eduardo F. Tizzano ^2,3

Myasthenia gravis: MuSK MG, late-onset MG and ocular MG

Feza Deymeer

Spinal cord injuries, human neuropathology and neurophysiology

Milan R. Dimitrijevic ^1,2, Byron A. Kakulas ³

Congresso Congiunto AIM – ASNP